Please login to the form below

Not currently logged in
Email:
Password:

MHLW

This page shows the latest MHLW news and features for those working in and with pharma, biotech and healthcare.

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace. Japan’s MHLW is next to approve the drug. ... Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Jivi (damoctocog alfa pegol/BAY94-9027) – a long-acting form of recombinant

Latest news

  • MSD’s Keytruda wins bladder cancer indication in Japan MSD’s Keytruda wins bladder cancer indication in Japan

    Bladder cancer patients living in Japan can now access Merck Sharp and Dohme’s (MSD) Keytruda (pembrolizumab) following a green light from the Japanese Ministry of Health, Labour and Welfare (MHLW).

  • Ono faces steep price cut for Opdivo in Japan Ono faces steep price cut for Opdivo in Japan

    The MHLW committee has accelerated that process by activating an emergency provision that allows earlier cuts for big-selling drugs – making 100bn to 150bn yen a year – and which exceed company

  • Japanese approvals for GSK, AZ and Bayer Japanese approvals for GSK, AZ and Bayer

    Japanese approvals for GSK, AZ and Bayer. MHLW gives Nucala, Tagrisso and Xofigo the green light. ... The Ministry of Health, Labour and Welfare (MHLW) gave the go-ahead to interleukin-5 inhibitor Nucala (mepolizumab) as a treatment for bronchial asthma

  • Takeda's once-weekly DPP-4 inhibitor cleared in first market Takeda's once-weekly DPP-4 inhibitor cleared in first market

    GlaxoSmithKline (GSK) has been given the go-ahead by the MHLW to market its long-acting muscarinic antagonist (LAMA) Encruse (umeclidinium) for chronic obstructive pulmonary disease (COPD). ... Amgen/Astellas' PCSK9-targeting antibody Repatha (evolocumab)

  • Novartis' Japanese subsidiary threatened with suspension Novartis' Japanese subsidiary threatened with suspension

    The company is staying tight-lipped about the reasons for the unusual action by the Ministry Of Health, Labour and Welfare (MHLW), although it has confirmed it has received a

More from news
Approximately 2 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    Ministry of Health, Labour and Welfare (MHLW) data revealed that the largest single cause of death was cancer, followed by stroke and heart disease. ... Additionally, if sales of a new drug are greater than estimated by the manufacturer, then its price

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics